Skip to content

Early Assessment of Cardiac Function Abnormalities in Patients with Ventricular Premature Contractions

Early Assessment of Cardiac Function Abnormalities in Patients with Ventricular Premature Contractions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120547
Enrollment
Unknown
Registered
2026-03-16
Start date
2026-03-16
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ventricular Contraction

Interventions

Healthy control group:None
Wide QRS Premature Ventricular Contractions:None
Narrow QRS Ventricular Premature Contractions Group:None

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age over 65 years; 2. Idiopathic Premature Ventricular Contractions (PVCs): High PVC burden demonstrated by 24-hour ambulatory electrocardiography (Holter) within the past month, with no identifiable etiology after comprehensive evaluation; 3. Normal Left Ventricular Function: Left ventricular ejection fraction (LVEF) measured by Simpson’s method on echocardiography within the past month =50%; 4. Asymptomatic or minimally symptomatic, with no prior treatment using Class I/III antiarrhythmic drugs (AADs) or radiofrequency ablation; 5. Duration of Premature Ventricular Contractions exceeding 1 year.

Exclusion criteria

Exclusion criteria: 1. Transthoracic echocardiography indicating left ventricular ejection fraction (LVEF) =50% and NT-proBNP>125 pg/mL), consistent with the recommendations of the "2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure". 3. Patients with arrhythmias other than premature ventricular contractions and short runs of ventricular tachycardia (such as atrial fibrillation, atrial flutter, frequent premature atrial contractions, conduction system diseases, etc.). 4. Currently using Class I/III antiarrhythmic drugs (AAD) or undergoing ablation therapy. 5. Other known diseases affecting left ventricular function, including hypertension, coronary artery disease, valvular heart disease, congenital heart disease, pulmonary heart disease, thyroid disease, severe hepatic or renal insufficiency, and other conditions affecting left ventricular function. 6. Patients with poor echocardiographic image quality that does not meet image analysis requirements.

Design outcomes

Primary

MeasureTime frame
Left Ventricular Global Work Efficiency;

Secondary

MeasureTime frame
Global Work Index;Effective Work;Non-Effective Work;Conventional Echocardiographic Parameters;

Countries

China

Contacts

Public ContactWen Heling

Sichuan Provincial People's Hospital

kavincardio@sina.com+86 28 8739 3999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026